Development of multiple cutaneous immune-related adverse events among cancer patients after immune checkpoint blockade: Supplemental File
Published: 14 June 2022| Version 1 | DOI: 10.17632/r4bsshkm6w.1
Contributors:
Maria Asdourian, Nishi Shah, Ted Jacoby, Yevgeniy Semenov, Tracey Otto, Leah Thompson, Edward Christopher Dee, Kerry Reynolds, Steven ChenDescription
This file discusses additional methodological details and includes a supplemental table summarizing cirAE characteristics in patients who developed multiple cirAEs after ICI therapy.
Files
Categories
Oncology, Dermatological Disease, Adverse Event, Medical Dermatology, Immune Checkpoint Blockade